Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: Aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli

Diabetologia

Volumn 42, Issue 7, 1999, Pages 878-886

  Sugimoto, H ^a   Shikata, K ^a   Wada, J ^a   Horiuchi, S ^b   Makino, H ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Aminoguanidine; Diabetic nephropathy; Nitric oxide

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; CARBOXYMETHYLLYSINE; CYTOKINE; LYSINE DERIVATIVE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; MALE; MESANGIUM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FRUCTOSAMINE; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY GLOMERULUS; MALE; NADPH DEHYDROGENASE; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STAINING AND LABELING; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032791602     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051241     Document Type: Article

References (17)

1. 1. The Diabetes Control and Complications Trial Data Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Eng J Med 329: 977-986
2. 2. Makino H, Shikata K, Hironaka K et al. (1995) Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 48: 517-526
3. 3. Shikata K, Makino H, Sugimoto H et al. (1995) Localization of advanced glycation endproducts in the kidney of experimental diabetic rats. J Diabetes Complications 9: 269-271
4. 4. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
5. 5. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157: 87-94
6. 6. Pfeilschifter J, Rob P, Mulsch A, Fandrey J, Vosbeck K, Busse R (1992) Interleukin-1-β and tumor necrosis factor-α induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem 203: 251-255
7. 7. Skolnik EN, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H (1990) Human and rat mesangial receptors glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathy J Exp Med 174: 631-939
8. 8. Brett J, Schmidt AM, Dan SD et al. (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712
9. 9. Sugimoto H, Shikata K, Makino H, Ota K, Ota Z (1996) Increased gene expression of insulin-like growth factor-1 receptor in experimental diabetic rat glomeruli. Nephron 72: 648-653
10. 10. Sugimoto H, Shikata K, Matsuda H, Oka K, Oka Z (1998) Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434
11. 11. Horiuchi S, Araki N, Morino Y (1991) Immunochemical approach to characterize advanced glycation end products of Maillard reaction. J Biol Chem 66: 7329-7332
12. 12. Miyatake N, Shikata K, Sugimoto H et al. (1998) Intercellular adhesion molecule-1 mediates mononuclear cell infiltration into rat glomeruli after renal ablation. Nephron 79: 91-98
13. 13. Pfeilschifter J, Vosbeck K (1991) Transforming growth factor β2 inhibits interleukin 1β and tumor necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Comm 175: 372-379
14. 14. Hasegawa G, Nakano K, Sawada M et al. (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40: 1007-1012
15. 15. Sugimoto H, Shikata K Hirata K et al. (1997) Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli-glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46: 2075-2081
16. 16. Soulis T, Cooper ME, Sastra S et al. (1997) Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia 40: 1141-1151
17. 17. Nathan C, Hibbs JB Jr (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70